Olema Pharmaceuticals, Inc. OLMA Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $49.23M+13.9% | $43.22M+8.2% | $39.95M-9.0% | $43.9M+43.4% | $30.62M-5.2% | ||
| $8.75M+27.5% | $6.86M+15.8% | $5.93M+49.6% | $3.96M-6.8% | $4.25M-4.9% | ||
| $57.99M+15.8% | $50.08M+9.2% | $45.88M-4.2% | $47.86M+37.3% | $34.87M-5.2% | ||
| $57.99M+15.8% | $50.08M+9.2% | $45.88M-4.2% | $47.86M+37.3% | $34.87M-5.2% | ||
| -$57.99M-15.8% | -$50.08M-9.2% | -$45.88M+4.2% | -$47.86M-37.3% | -$34.87M+5.2% | ||
| $4.78M+19.1% | $4.01M+9.9% | $3.65M-9.7% | $4.04M-10.7% | $4.52M+37.3% | ||
| $4.9M+21.7% | $4.02M+9.9% | $3.66M-10.3% | $4.08M-9.0% | $4.48M+40.1% | ||
| -$53.09M-15.3% | -$46.06M-9.1% | -$42.22M+3.6% | -$43.78M-44.1% | -$30.39M+9.5% | ||
| -$0.52-2.0% | -$0.51-4.1% | -$0.49+3.9% | -$0.51-41.7% | -$0.36+10.0% | ||
| -$0.52-2.0% | -$0.51-4.1% | -$0.49+3.9% | -$0.51-41.7% | -$0.36+10.0% | ||
| 102.8M+18.2% | 87M+1.5% | 85.7M+0.3% | 85.5M+0.1% | 85.4M+45.4% | ||
| 102.8M+18.2% | 87M+1.5% | 85.7M+0.3% | 85.5M+0.1% | 85.4M+45.4% | ||
| $121K+831% | $13K+8.3% | $12K-68.4% | $38K+195% | -$40K— | ||
| -$57.99M-15.8% | -$50.08M-9.2% | -$45.88M+4.2% | -$47.86M-37.3% | -$34.87M+5.2% | ||
| -$57.87M-16.0% | -$49.9M-8.9% | -$45.83M+4.0% | -$47.73M-37.4% | -$34.75M+5.2% | ||
| -$57.87M-16.0% | -$49.9M-8.9% | -$45.83M+4.0% | -$47.73M-37.4% | -$34.75M+5.2% | ||
| -$57.99M-15.8% | -$50.08M-9.2% | -$45.88M+4.2% | -$47.86M-37.3% | -$34.87M+5.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Olema Pharmaceuticals, Inc. profitable?
- Olema Pharmaceuticals, Inc. is not currently profitable: it reported a net loss of $185.2M over the trailing twelve months.
- What is Olema Pharmaceuticals, Inc.'s earnings per share?
- Olema Pharmaceuticals, Inc.'s diluted EPS over the trailing twelve months is $-2.03.
- Where does Olema Pharmaceuticals, Inc.'s income statement data come from?
- Every line is extracted from Olema Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.